Further studies indicate that glutamine serves as both a nitrogen and carbon source in prostate cancer, with higher expression of glutamine transporters (ASCT2), GDH1, AST1, and GLUL (Glutamine synthetase). This evidence concerns the gene SLC1A5 and prostate cancer.